Distribution of intraperitoneal gold colloid (198-Au)

Area of Science:

• Biomedical science
• Radiopharmacology

Background:

• Intraperitoneal administration is a common route for drug delivery.
• Understanding the biodistribution of radiocolloids is crucial for therapeutic and diagnostic applications.

Purpose of the Study:

• To investigate the distribution and clearance of intraperitoneally injected 198-Au colloid in a murine model.
• To determine the retention time and primary accumulation sites of 198-Au colloid in mice.

Main Methods:

• Mice were administered intraperitoneal injections of 198-Au colloid.
• Radioactivity levels were measured at various time points post-injection (8 hours and 7 days).
• Tissue distribution analysis focused on key organs, particularly the greater omentum and mesenteric lymph nodes.

Main Results:

• A significant portion of radioactivity (49%) persisted 8 hours after intraperitoneal injection.
• 9% of the initial radioactivity remained detectable after 7 days, indicating slow clearance.
• The highest concentrations of 198-Au colloid were found in the greater omentum and mesenteric lymph nodes.

Conclusions:

• Intraperitoneally injected 198-Au colloid exhibits prolonged retention in mice.
• The greater omentum and mesenteric lymph nodes are primary accumulation sites for this radiocolloid.
• These findings have implications for targeted drug delivery and radiotherapy strategies using intraperitoneal administration.